Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Counselling: filling a gap in general practice.
Nettleton B, Cooksey E, Mordue A, Dorward I, Ferguson J, Johnston J, Jones L. Nettleton B, et al. Among authors: jones l. Patient Educ Couns. 2000 Sep;41(2):197-207. doi: 10.1016/s0738-3991(00)00089-6. Patient Educ Couns. 2000. PMID: 12024544
Development of a Children's Trust in General Physicians Scale.
Rotenberg KJ, Cunningham J, Hayton N, Hutson L, Jones L, Marks C, Woods E, Betts LR. Rotenberg KJ, et al. Among authors: jones l. Child Care Health Dev. 2008 Nov;34(6):748-56. doi: 10.1111/j.1365-2214.2008.00872.x. Child Care Health Dev. 2008. PMID: 18959573
Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC).
Sun V, Thomson CA, Crane TE, Arnold KB, Guthrie KA, Freylersythe SG, Braun-Inglis C, Jones L, Carmichael JC, Messick C, Flaherty D, Ambrale S, Cohen SA, Krouse RS. Sun V, et al. Among authors: jones l. Support Care Cancer. 2024 May 22;32(6):371. doi: 10.1007/s00520-024-08527-x. Support Care Cancer. 2024. PMID: 38775966
Qualitative analysis of the factors associated with whistleblowing intentions among athletes from six European countries.
Toner J, Jones L, Fairs L, Mantis C, Barkoukis V, Daroglou G, Perry JL, Micle AV, Theodorou NC, Shakhverdieva S, Stoicescu M, Pompiliu-Nicolae C, Vesic MV, Dikic N, Andjelkovic M, Revilla JM, García-Grimau E, Martínez MAE, Amigo JA, Schomöller A, Nicholls AR. Toner J, et al. Among authors: jones l. Front Sports Act Living. 2024 May 7;6:1335258. doi: 10.3389/fspor.2024.1335258. eCollection 2024. Front Sports Act Living. 2024. PMID: 38774279 Free PMC article.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00549-X. doi: 10.1016/S0140-6736(24)00549-X. Online ahead of print. Lancet. 2024. PMID: 38763153 Free article.
RIFM fragrance ingredient safety assessment, thymol, CAS Registry Number 89-83-8.
Api AM, Bartlett A, Belsito D, Botelho D, Bruze M, Bryant-Freidrich A, Burton GA Jr, Cancellieri MA, Chon H, Dagli ML, Dekant W, Deodhar C, Farrell K, Fryer AD, Jones L, Joshi K, Lapczynski A, Lavelle M, Lee I, Moustakas H, Muldoon J, Penning TM, Ritacco G, Sadekar N, Schember I, Schultz TW, Siddiqi F, Sipes IG, Sullivan G, Thakkar Y, Tokura Y. Api AM, et al. Among authors: jones l. Food Chem Toxicol. 2024 May 16:114739. doi: 10.1016/j.fct.2024.114739. Online ahead of print. Food Chem Toxicol. 2024. PMID: 38761873 No abstract available.
RIFM fragrance ingredient safety assessment, 3-methyl-2-butenyl benzoate, CAS Registry Number 5205-11-8.
Api AM, Bartlett A, Belsito D, Botelho D, Bruze M, Bryant-Freidrich A, Burton GA Jr, Cancellieri MA, Chon H, Dagli ML, Dekant W, Deodhar C, Farrell K, Fryer AD, Jones L, Joshi K, Lapczynski A, Lavelle M, Lee I, Moustakas H, Muldoon J, Penning TM, Ritacco G, Sadekar N, Schember I, Schultz TW, Siddiqi F, Sipes IG, Sullivan G, Thakkar Y, Tokura Y. Api AM, et al. Among authors: jones l. Food Chem Toxicol. 2024 May 15;189 Suppl 1:114735. doi: 10.1016/j.fct.2024.114735. Online ahead of print. Food Chem Toxicol. 2024. PMID: 38759717 No abstract available.
8,369 results